You are here: Industry Insights > PMA

News List

Allarity Therapeutics Receives Acceptance & Review Notification from U.S. FDA for Pre-Market Approval Application for Dovitinib-DRP firstwordpharma
July 06, 2021
Allarity Therapeutics A/S ("Allarity" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has provided a positive administrative acceptance and review notification for the Company's PMA application for its Dovitinib-DRP®
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval biospectrumasia
September 18, 2019
The pivotal studies leading to the RECELL System’s FDA premarket approval (PMA) for the treatment of acute thermal burns demonstrated that the RECELL System treated burns using 97.5 percent less donor skin when used alone in second-degree burns, and 32 pe
PMA announces free eye surgeries by Chinese doctors biospectrumasia
November 15, 2017
This is in pursuance of the collaboration of the medical associations of the two countries to strengthen the Pakistan-China medical corridor.